Indian auto delegation yet to leave for China for talks to expedite supply of rare earth magnets
Synopsis
Indian auto industry representatives are facing delays in their trip to China to secure rare earth magnet imports, crucial for automotive manufacturing. The delegation awaits formal approval from the Chinese commerce ministry despite holding visas.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
12 minutes ago
- Business Standard
NxtQuantum AI-powered 5G smartphones to be next market giant-killer
Currently, the cheapest 5G smartphones in India are priced above ₹8,000. Sheth's latest offering promises not just affordability, but also compatibility with standalone and non-standalone 5G networks premium Surajeet Das Gupta New Delhi Listen to This Article Madhav Sheth, founder of NxtQuantum Shift Technologies and the man behind Realme's meteoric rise in India, is laying the groundwork to launch an ultra-affordable, AI-powered 5G smartphone, priced under ₹ 5,000. Currently, the cheapest 5G smartphones in India are priced above ₹8,000. Sheth's latest offering promises not just affordability, but also compatibility with standalone and non-standalone 5G networks. 'We don't have a truly successful Indian smartphone brand today — that's the gap we're aiming to fill,' Sheth told Business Standard, who after quitting Realme tried bringing back the Honor brand to India with limited success. 'Our goal is to sell
Indian Express
13 minutes ago
- Indian Express
Torrent to buy 46.39 pc stake in JB Chemicals for Rs 11,917 crore
In a significant acquisition in the pharmaceutical sector, Torrent Pharmaceuticals Ltd on Sunday entered into definitive agreements to acquire controlling stake of 46.39 per cent stake in J. B. Chemicals and Pharmaceuticals from global investment firm KKR for Rs 11,917 crore at a price of Rs 1,600 per share. Torrent will also make a mandatory open offer to acquire another 26 per cent of JB Pharma shares from public shareholders at an open offer price of Rs 1,639.18 per share. After the open offer, the total cost of acquisition will come to Rs 13,556 crore. The acquisition was made at an equity valuation of Rs 25,689 crore (on fully diluted basis), followed by a merger of the two entities. The transaction marks a significant step in Torrent's ambition to create a future-ready, diversified healthcare platform combining a deep chronic segment heritage with emerging international CDMO (contract development and manufacturing organization) capabilities. As per the approval given by the board of directors of both companies, after the merger of JB Pharma with Torrent, every shareholder holding 100 shares in JB Pharma will receive 51 shares of Torrent. In addition to this, Torrent has also expressed its intent to acquire up to 2.80% of equity shares from certain employees of JB Pharma at the same price per share as KKR. The merger between Torrent and JB Pharma will be through a scheme of arrangement. KKR, a US-based private equity giant, acquired about 54 per cent stake in JB Chemicals and Pharmaceuticals, one of the oldest pharma companies in India, for Rs 3,100 crore in July 2020. It acquired the stake from the founding Mody family at a purchase price of Rs 745 per share and made an open offer for an additional 26 per cent of the company. Samir Mehta, Executive chairman, Torrent, said: 'Torrent's deep India presence and JB Pharma's fast growing India business, combined with the CDMO and international footprint offers immense potential to scale both revenue and profitability. This strategic alignment furthers our goal of strengthening our presence in the Indian pharma market, and build a larger diversified global presence. Moreover, the CDMO platform provides a new long-term avenue of growth for Torrent.' Torrent Pharma, which has a market valuation of Rs 1.13 lakh crore, closed higher by 3.68 per cent at Rs 3344.40 on the BSE on Friday. JB Chemicals, with a market capitalisation of Rs 28,080 crore, reported a revenue of Rs 3,722 crore in FY25. Its shares closed 2.72 per cent higher at Rs 1799.35 on the BSE. Torrent Pharma, with annual revenues of more than Rs 11,500 crore, is the flagship company of the Torrent Group, with group revenues of Rs 45,000 crore. It is amongst the top 5 in the therapeutics segments of cardiovascular (CV), gastro Intestinal (GI), central nervous system (CNS) and cosmo-dermatology. It is a specialty-focused company with 76 per cent of its revenues in India from chronic and sub- chronic therapies. It has presence in 50 plus countries. Torrent has 8 manufacturing facilities, of which 5 are USFDA approved. JB Pharma is one of the fastest growing pharmaceutical companies in India and a leading player in the hypertension segment. Besides its strong India presence, which accounts for majority of its revenue, its other two home markets are Russia and South Africa. In India, the company has six brands among the top 300 IPM brands in the country. It has eight state-of-the-art manufacturing facilities in India including a dedicated manufacturing facility for lozenges
Hans India
14 minutes ago
- Hans India
‘GoIStats' mobile app launched for real-time access to official statistical data
New Delhi: The government on Sunday launched the 'GoIStats' mobile application that will help every stakeholder seamlessly access official data on the go. The initiative by the National Sample Survey Office (NSO), under the Ministry of Statistics and Programme Implementation (MoSPI), is a significant milestone in India's commitment to making official statistics accessible and user-centric for all citizens. The GoIStats mobile application represents NSO's vision of creating an all-encompassing data ecosystem. The application features an interactive "Key Trends" dashboard showcasing important socio-economic indicators with dynamic visualisations of critical metrics including GDP, inflation, employment data. Users gain direct access to NSO's database through the "Products" section, featuring one-click CSV downloads. Advanced filtering and search capabilities with comprehensive metadata, and mobile-optimised data tables are also available for seamless viewing, according to the ministry. The app's visual data storytelling capabilities include a curated infographics section that transforms complex statistics into digestible insights, interactive charts and graphs with contextual explanations, social sharing features to promote data literacy across communities, and complete source attribution for each visualisation following principles of transparency and trust. Moreover, a comprehensive publication section provides users with the access to NSO reports and publications with instant download functionality. Regular updates aligned with NSO's publication calendar are provided to the user with app notification facility. Feedback mechanism for continuous app improvement, a user-friendly interface and direct communication channels through the "Contact Us" section are some of the features designed for user empowerment. Currently the Android version of mobile application is available free of charge on google play store. The iOS version will be released shortly. 'This initiative completes the ideal digital bouquet of website, portal and mobile app expected from a data producing organisation. GoIStats empowers every Indian to meaningfully engage with government data, strengthening citizen participation in building a Viksit Bharat,' said the ministry.
